FLT3L诱导的虚拟记忆CD8T细胞与免疫系统对抗瘤
Hsin-Fang Tu1, Yu-Jui Kung2, Ling Lim1
1Department of Pathology, Johns Hopkins University School of Medicine, 1550 Orleans Street, CRB II 307, Baltimore, MD, 21287, USA.
Journal of biomedical science
|January 29, 2024
概括
类似FMS的氨酸激酶3连接体 (FLT3L) 增强了具有虚拟记忆特性的CD8T细胞,改善了抗瘤免疫力. 这种免疫调节显示了癌症免疫疗法的治疗潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 细胞免疫学 细胞免疫学
背景情况:
- 类似FMS的氨酸激酶3连接体 (FLT3L) 研究一直专注于树突细胞的产生,对其对CD8 T细胞功能的影响的理解有限.
- 这项研究调查了FLT3L在调节CD8T细胞免疫调节能力方面的体内作用.
研究的目的:
- 阐明FLT3L对CD8T细胞功能和抗瘤反应的体内影响.
- 揭示FLT3L调节CD8T细胞的潜在机制,包括JAK-STAT1信号传导和血细胞树突细胞 (pDC) 的作用.
主要方法:
- 用于分析CD8T细胞的反应,对小鼠进行了专结合FLT3L (Alb-FLT3L) 的治疗.
- 收养细胞转移到携带瘤的小鼠中评估了 Alb-FLT3L 前置条件对瘤进展的影响.
- 大量RNA-seq,STAT1缺乏的小鼠,抗体阻塞和体外共养实验被用来确定作用机制.
主要成果:
- Alb-FLT3L治疗增强了CD44高CD8的T细胞,表现出虚拟记忆特征和改进的效应器功能.
- 这些增强的CD8 T细胞的采用转移导致了小鼠模型中显著的瘤回归.
- FLT3L诱导的CD8T细胞调节取决于JAK-STAT1信号和I型干扰素,pDCs发挥着关键的调解作用.
结论:
- FLT3L的使用有效地预先条件了原始的CD8T细胞,增强了它们的抗瘤能力.
- 作为癌症免疫疗法的免疫调节器,Alb-FLT3L显示出显著的治疗潜力.
更多相关视频
10:44A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants
Published on: August 9, 2019
7.3K
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.4K
相关概念视频
Cytotoxic T Cells-mediated Immune Response
917
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
917
T Cell Activation and Clonal Selection
735
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
735
Tumor Immunotherapy
526
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
526
T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
